New Report Projects 11 Percent Annual Growth in Genomically Guided Personalized Medicine | GenomeWeb

NEW YORK (GenomeWeb News) – A new report by PricewaterhouseCoopers estimates the $232 billion personalized medicine market will grow 11 percent annually.

According to the professional services firm, the trend toward tailoring drugs based on clinical factors and genomic variation will create opportunities and challenges for the pharmaceutical and biotech industries. As far as the opportunities, however, the market for "a more personalized approach to health and wellness will grow to as much as $452 billion by 2015," PricewaterhouseCooper gauges.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genetic method to gauge age of ancient samples, genetic polymorphisms in mouse strain, and more.

Two Stanford professors are turning to the online game EteRNA to develop a new way to diagnose tuberculosis.

Lita Nelsen from the Massachusetts Institute of Technology's technology-transfer office is retiring after decades there.

After nine years, the Canadian government is loosening its restrictions on government scientists' ability to speak to the press and public.